| scholarly article | Q13442814 |
| P50 | author | Christopher K. Fairley | Q37374066 |
| Suzanne Marie Garland | Q87258284 | ||
| Sepehr N Tabrizi | Q87723657 | ||
| P2093 | author name string | Catriona S Bradshaw | |
| Carol A Hopkins | |||
| Jorgen S Jensen | |||
| Lorna M Moss | |||
| Timothy R H Read | |||
| P2860 | cites work | Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR. | Q34228320 |
| Quantitative detection of Mycoplasma genitalium from first-pass urine of men with urethritis and asymptomatic men by real-time PCR | Q34454901 | ||
| Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure | Q34481060 | ||
| Tetracycline treatment does not eradicate Mycoplasma genitalium | Q35530803 | ||
| Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases | Q35608986 | ||
| Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis | Q37873766 | ||
| Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden | Q37876488 | ||
| In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. | Q40469366 | ||
| In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. | Q46736886 | ||
| In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas | Q73510400 | ||
| Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp | Q73819627 | ||
| Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro | Q77695140 | ||
| P433 | issue | 7 | |
| P921 | main subject | azithromycin | Q165399 |
| urethritis | Q1122485 | ||
| Mycoplasma genitalium | Q1930909 | ||
| P304 | page(s) | 1149-1152 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | Azithromycin failure in Mycoplasma genitalium urethritis | |
| P478 | volume | 12 |
| Q33810064 | 'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women' |
| Q37854784 | 2009 European guideline on the management of male non-gonococcal urethritis |
| Q34657350 | 2012 European guideline for the management of pelvic inflammatory disease. |
| Q37840512 | 2015 UK National Guideline on the management of non-gonococcal urethritis. |
| Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
| Q37838437 | Advances in the Understanding and Treatment of Male Urethritis |
| Q26782567 | Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections |
| Q38040151 | Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis |
| Q42111508 | Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. |
| Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
| Q40397194 | Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance |
| Q46340504 | Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study |
| Q46260038 | Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance |
| Q37855464 | Azithromycin treatment for nongonococcal urethritis negative for Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum |
| Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
| Q36376238 | Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy |
| Q37845223 | Clinical Efficacy of a Single Two Gram Dose of Azithromycin Extended Release for Male Patients with Urethritis |
| Q42232089 | Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides |
| Q37844334 | Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts |
| Q37346157 | Diagnosis and treatment of pelvic inflammatory disease. |
| Q37713726 | Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis |
| Q35656598 | Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial |
| Q38646438 | Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections |
| Q34591252 | Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. |
| Q36971250 | Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium |
| Q37579937 | High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. |
| Q94417391 | In Reply |
| Q40103287 | In Vitro Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents Against Human Mycoplasmas and Ureaplasmas |
| Q24605678 | Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis |
| Q41583528 | Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens |
| Q43180518 | Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan |
| Q64999477 | Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017. |
| Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
| Q40359795 | Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection |
| Q36043585 | Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology |
| Q55234408 | Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. |
| Q58115544 | Mycoplasma genitalium adhesin P110 binds sialic-acid human receptors |
| Q34076727 | Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics |
| Q37387569 | Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics |
| Q37846695 | Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan |
| Q58699936 | Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance |
| Q40084684 | Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women |
| Q27021073 | Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations |
| Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
| Q40124458 | Mycoplasma genitalium on the Loose: Time to Sound the Alarm |
| Q43136741 | Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads |
| Q35008363 | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey |
| Q26747053 | Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women? |
| Q51506151 | Mycoplasma genitalium: Is It a Sexually Transmitted Pathogen? |
| Q34403627 | Mycoplasma genitalium: a review |
| Q35090137 | Mycoplasma genitalium: from Chrysalis to multicolored butterfly |
| Q35542157 | Mycoplasma genitalium: should we treat and how? |
| Q37869911 | Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. |
| Q37592110 | Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda |
| Q38609857 | New Horizons in Mycoplasma genitalium Treatment |
| Q31154685 | Nongonococcal urethritis: new views through the prism of modern molecular microbiology |
| Q33382111 | Persistence of Mycoplasma genitalium following azithromycin therapy |
| Q37844177 | Prevalence of Trichomonas vaginalis, Mycoplasma genitalium and Ureaplasma urealyticum in men with urethritis attending an urban sexual health clinic |
| Q33721540 | Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance |
| Q34269050 | Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium |
| Q34155769 | Recommendations and rationale for the treatment of pelvic inflammatory disease |
| Q42212384 | Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. |
| Q47140897 | Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model |
| Q36656274 | Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial |
| Q96230220 | Structure and mechanism of the Nap adhesion complex from the human pathogen Mycoplasma genitalium |
| Q27314938 | Structure-Guided Mutations in the Terminal Organelle Protein MG491 Cause Major Motility and Morphologic Alterations on Mycoplasma genitalium |
| Q37850895 | Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin |
| Q47661785 | Sustained Simultaneous Delivery of Metronidazole and Doxycycline From Polycaprolactone Matrices Designed for Intravaginal Treatment of Pelvic Inflammatory Disease |
| Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
| Q34261217 | The evolution of Mycoplasma genitalium. |
| Q41046965 | Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women |
| Q34245136 | Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis |
| Q37859744 | Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum |
Search more.